C-RAD, a global leader in surface-guided radiation therapy (SGRT), has signed a premium service agreement with a prominent healthcare provider based on the U.S. East Coast. The multiyear contract, valued at approximately 8 MSEK, builds on a relationship spanning almost a decade and marks an important step in advancing continuity, efficiency, and clinical precision across the provider’s radiation oncology program. The order was signed and recognized as order intake in the second quarter.
The customer’s clinical setup includes multiple Catalyst+ HD and Sentinel 4DCT systems. The new agreement reflects a strategic effort to simplify service management and support long-term system performance and continuity.
“This important partnership demonstrates the provider’s continued confidence in C-RAD’s technology and our team,” says Cecilia de Leeuw, President and CEO of C-RAD. “It underscores the long-term value of our solutions and our ability to deliver consistent, high-quality support. We look forward to deepening our collaboration and helping clinicians advance the standard of care in radiation therapy.”
The key milestone underscores C-RAD’s continued ambition to grow in the U.S. market and supports its broader mission to improve cancer treatment outcomes through innovation and patient-centered technologies. C-RAD remain focused on delivering clinically proven solutions that enable greater precision, workflow efficiency, and safety in radiotherapy.